Category Archive for "Health Systems Research"

Integrated Bio-behavioral surveillance and population size estimation survey among Female Sex Workers in Tbilisi and Batumi, Georgia

This study represents the subsequent wave of BBS surveys undertaken among FSWs since 2002. The current study was conducted in 2017 using the Time-Location Sampling technique and 350 FSWs was recruited in total in two survey locations – 200 in Tbilisi and 150 – in Batumi.

Read More

The Interview on population size and Human Immunodeficiency Virus risk behaviors of People who Inject Drugs in Georgia

The interview is based on the latest wave of the integrated Bio- behavioral surveillance survey conducted People Who Inject drugs (PWID) in 7 cities of Georgia. The research aims to mesure the prevalence of Human Immunodeficiency Virus (HIV) and Hepatitis C virus (HCV) among PWID, define key risk behaviors related to HIV and generate evidence for advocacy and policy development.

Read More

Conference paper about realist evaluation: Informing policy, assessing its effects and understanding how it works for improved Tuberculosis management in Georgia

At the conference research team introduced insights of using Realist Evaluation to not only elicit the Programme Theory of the policy-makers and implementers, but also of the researchers.

Read More

Results4TB: Designing and evaluating provider Results Based Financing for Tuberculosis in Georgia

“Designing and evaluating provider results-based financing for tuberculosis care in Georgia: understanding costs, mechanisms of effect and impact”. The 48-month duration research project will assist the Government of Georgia in developing a provider incentive payment scheme for Tuberculosis (as a pilot intervention) and will generate evidence on its effects on adherence and treatment success rates and costs.

Read More

Article: Determinants analysis of outpatient service utilization in Georgia: can the approach help inform benefit package design?

Curatio International Foundation conducted secondary data analyses of Health Service Utilization and Expenditure survey (2 waves), conducted by Ministry of Labor Health and Social Affairs of Georgia, supported by WHO and The World Bank. We studied factors that impact utilization…

Read More

Designing and evaluating provider results-based financing for tuberculosis care in Georgia (RBF4TB)

Introduction and Overview CIF in partnership with Queen Margaret University (UK), London School of Hygiene and Tropical Medicine (UK) and Antwerp Institute of Tropical Medicine (Belgium) is implementing a study “Designing and evaluating provider results-based financing for tuberculosis care in…

Read More

Barriers and Facilitators to Adherence to Treatment Among Drug Resistant TB Patients in Georgia

Tuberculosis is a global challenge to public health throughout the world. Poor adherence to treatment remains a significant problem that prevents countries from obtaining high treatment success rates that is essential for health systems to control the epidemic and decrease

Read More

New Study Findings About Tuberculosis

Curatio International Foundation together with the Partnership for Research and Action for Health organized a meeting at the National Center for Disease Control and Public Health on 26th of December, where two different study findings were represented. Studies aimed to…

Read More

Article: Privilege and inclusivity in shaping Global Health agendas

Health Policy and Planning published an article Privilege and inclusivity in shaping Global Health agendas.  CIF director George Gotsadze co-authors the paper together with Kabir Sheikh, Sara Bennett and Fadi el Jardali. The article discusses lack of inclusivity in Global Health…

Read More

Barriers and Facilitators to Screening and Treatment of HCV among IV drug-users in the Republic of Georgia: A Formative Qualitative Study

Status: Closed Introduction and Overview In Georgia HCV treatment has become accessible to the population through a new government initiative. This initiative entails the provision of costly HCV treatment drugs at a lower cost (60% lower than the market price)…

Read More